The global single-use bioreactors market size is expected to reach USD 17.97 billion by 2030 according to a new study by Polaris Market Research. The report “Single-use Bioreactors Market Share, Size, Trends, Industry Analysis Report, By Product (Bioreactor Systems, Media Bags, Filtration Assemblies, Others); By Cell (Mammalian, Bacteria, Yeast, Others); By Molecule; End-Use; By Region; Segment Forecast, 2022 - 2030” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The escalating demand for single-use bioreactors is attributed to the factors such as the rising penetration of SUBs, majorly in startups, and small companies, coupled with the technological developments in the SUBs. In addition, research and development in the biopharmaceutical industry and growth of the biologics market are also spurring the industry demand. Moreover, increasing inclination towards the multi?drug facilities requires the production of a wide range of drugs, in the least time with minimum costs by the utilization of the same facility, which, in turn, leads to the single-use bioreactors industry growth.
Based on the end-use, the pharmaceutical and biopharmaceutical market segment holds the highest shares in the global industry in 2021, owing to the rapid deployment of innovative technologies and the rising number of government initiatives. Whereas the contract research organization (CRO) is likely to rise at the highest CAGR in the foreseen years. The increasing number of R&D activities by the pharmaceutical industry is anticipated to support the CRO segment.
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/single-use-bioreactors-market/request-for-sample
Based on the end-use, the pharmaceutical and biopharmaceutical industry segment is holding the highest shares in the global market in 2021, owing to the rapid deployment of innovative technologies, rising number of government initiatives. The increasing cases of numerous diseases are exhibiting the high demand for single-use bioreactors. Some critical disease outbreaks have occurred over the last several decades, such as H1N1 virus, influenza, dengue, Zika virus, and chikungunya, which are majorly spread by insect and pest vectors. In 2017, the Zika virus epidemic across America was the most recent epidemic, which was transmitted by A. aegypti and A. albopictus.
Major participants such as Merck Millipore, Eppendorf AG, ABLE Corporation & Biott Corporation, BBI-Biotech GMBH, Celltainer Biotech BV, Cesco Bioengineering Co., Ltd., Danaher Corporation, Meissner Filtration Products, Inc., Distek, Inc., G&G Technologies, Inc., Thermo Fisher Scientific Inc., Getinge AB, PBS Biotech, Inc., Sartorius AG, Solida Biotech GMBH, Stobbe Pharma GMBH, and Cellexus are some of the key players operating in the global market.
Polaris Market Research has segmented the single-use bioreactors market report on the basis of product, cell, molecule, end-use, and region:
Single-use Bioreactors, Product Outlook (Revenue - USD Billion, 2018 - 2030)
Single-use Bioreactors, Cell Outlook (Revenue - USD Billion, 2018 - 2030)
Single-use Bioreactors, Molecule Outlook (Revenue - USD Billion, 2018 - 2030)
Single-use Bioreactors, End-Use Outlook (Revenue - USD Billion, 2018 - 2030)
Single-use Bioreactors, Regional Outlook (Revenue - USD Billion, 2018 - 2030)